155 related articles for article (PubMed ID: 38476014)
21. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Collins J; Zhang Z; Xu C; Subramanian SV; Kawachi I; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1419-1424. PubMed ID: 30354025
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of fetal and maternal pregnancy outcomes in Japanese patients with systemic lupus erythematosus.
Irino K; Arinobu Y; Ayano M; Kawano S; Kimoto Y; Mitoma H; Akahoshi M; Akashi K; Horiuchi T; Niiro H
Lupus; 2021 Sep; 30(10):1637-1643. PubMed ID: 34266321
[TBL] [Abstract][Full Text] [Related]
23. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
Abe Y; Tada K; Yamaji K; Tamura N
Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682
[TBL] [Abstract][Full Text] [Related]
24. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
[TBL] [Abstract][Full Text] [Related]
25. Preterm deliveries in women with systemic lupus erythematosus.
Clark CA; Spitzer KA; Nadler JN; Laskin CA
J Rheumatol; 2003 Oct; 30(10):2127-32. PubMed ID: 14528505
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy Outcomes in Systemic Lupus Erythematosus Women: A single tertiary centre experience.
Al-Riyami N; Salman B; Al-Rashdi A; Al-Dughaishi T; Al-Haddabi R; Hassan B
Sultan Qaboos Univ Med J; 2021 May; 21(2):e244-e252. PubMed ID: 34221472
[TBL] [Abstract][Full Text] [Related]
27. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study.
Vinet É; Pineau CA; Scott S; Clarke AE; Platt RW; Bernatsky S
Circulation; 2015 Jan; 131(2):149-56. PubMed ID: 25355915
[TBL] [Abstract][Full Text] [Related]
28. Neonatal Outcomes in Pregnant Women with Systemic Lupus Erythematosus: A 13-Year Experience in Southern Thailand.
Pakhathirathien P; Janjindamai W; Dissaneevate S; Thatrimontrichai A; Maneenil G
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34345902
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.
Koh JH; Ko HS; Kwok SK; Ju JH; Park SH
Lupus; 2015 Feb; 24(2):210-7. PubMed ID: 25305214
[TBL] [Abstract][Full Text] [Related]
30. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.
Sharma SK; Jain S; Bahl P; Potturi P; Rathi M; Naidu S; Sachdeva N; Dhir V; Jain S
Arthritis Res Ther; 2020 Aug; 22(1):189. PubMed ID: 32799907
[TBL] [Abstract][Full Text] [Related]
31. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH
Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
Pisoni CN; Karim Y; Cuadrado MJ
Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
[TBL] [Abstract][Full Text] [Related]
33. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.
Harward LE; Mitchell K; Pieper C; Copland S; Criscione-Schreiber LG; Clowse ME
Lupus; 2013 Jan; 22(1):81-6. PubMed ID: 23263867
[TBL] [Abstract][Full Text] [Related]
34. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
Al Arfaj AS; Khalil N
Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.
Chomistek AK; Phiri K; Doherty MC; Calderbank JF; Chiuve SE; McIlroy BH; Snabes MC; Enger C; Seeger JD
Drug Saf; 2023 Feb; 46(2):209-222. PubMed ID: 36656445
[TBL] [Abstract][Full Text] [Related]
39. Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births.
Kroese SJ; de Hair MJH; Limper M; Lely AT; van Laar JM; Derksen RHWM; Fritsch-Stork RDE
J Immunol Res; 2017; 2017():2810202. PubMed ID: 29392142
[TBL] [Abstract][Full Text] [Related]
40. Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE).
Cavallasca JA; Laborde HA; Ruda-Vega H; Nasswetter GG
Clin Rheumatol; 2008 Jan; 27(1):41-6. PubMed ID: 17516127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
